On January 18, 2023, Research-Aid Networks and others sent a rapid response to BMJ regarding the study ‘Long covid outcomes at one year after mild

We recently published a collaborative commentary in Lancet Child & Adolescent Health raising methodological concerns about a recent study that minimizes the risks of Long COVID in children.

Big changes, small differences, one constant – the ABCs of COVID A lot has changed since the world encountered the novel virus commonly known as

With the simultaneous arrival of both the holidays and the Omicron variant, many of us are left wondering what this means for the holiday season

We recently published a collaborative article in Nature Medicine discussing the promotion of non-evidence based therapeutics in Long COVID support groups.

We assisted our partners from Europe, a Patient with the organising of a conference in collaboration with the Pontifical Academy of Social Sciences and the

Recently, Pandemic-Aid Networks has issued an international call for school safety measures in order to protect children, teachers, families and communities from COVID-19. In collaboration

Clinical trials are still investigating the effectiveness of COVID-19 booster jabs, while the UK Government have said millions may be offered a third jab from

In collaboration with Pandemic-Aid Networks, we launched in 2021 an online interview series focusing on Long COVID. Named after the difficult journey those suffering from this unknown

Research-Aid Networks, in collaboration with the advocacy group LongCovidSOS, the University of Exeter and the University of Kent launched a survey to find out how

Guide to the COVID-19 Pandemic     Key Points Check your local COVID dashboard and know your local situation. If you’re in an area where

On Monday 24 May 2021, 6:30pm BST // 7:30pm CEST Zero Covid Coalition, Morning Star and Pandemic-Aid Networks held on online event: We Need A People’s Vaccine By

We have all heard about the new COVID-19 variant (B.1.1.7) that is spreading rapidly in the South of England and has been found in Denmark, the

Much of the world’s hope in controlling the COVID-19 pandemic rests on the creation and distribution of a safe and effective vaccine. While there has

Pandemic-Aid Networks is an umbrella platform for COVID-19 advocacy groups, Long Covid groups and other COVID-focused groups and organizations across the globe. The network is

Lockdown is easing. People are returning to work and shops are lifting their shutters. But we don’t have a vaccine and we’re a long way from achieving herd

While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach to containing the

A few months ago, most people had never heard of the R number. Now, thanks to the novel coronavirus, we all know – or think

Matt Hancock, the UK health secretary, promised 100,000 coronavirus tests a day by the end of April. On the last day of the month, the

The UK Paediatric Intensive Care Society sent out an alert on April 27 about an increase in cases of severe COVID-19-related illness in children. Since then, 19 cases have been

As case numbers of COVID-19 continue to rise around the world, we are starting to see an increasing number of reports of neurological symptoms. Some

For COVID-19, age and sex appear to be strong predictors of who lives and who dies. The fatality rate for the disease is estimated to be 0.66%,

There have been some cases, but is it too early to tell what is actually happening here? There have been a few stories in the

Within four months, the UK will have 66,314 fatalities from COVID-19, according to a recent report from the University of Washingon’s Institute for Health Metrics and Evaluation

Germany has received a great deal of attention for having a lower death rate for COVID-19 than most comparable European countries. A simple explanation for the